EGFR mutation of tumor and serum in gefitinib-treated patients with chemotherapy-naive non-small cell lung cancer. [electronic resource]
Producer: 20070502Description: 260-7 p. digitalISSN:- 1556-1380
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- adverse effects
- Biomarkers, Tumor -- blood
- Carcinoma, Large Cell -- drug therapy
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- DNA -- blood
- ErbB Receptors -- genetics
- Exons
- Female
- Gefitinib
- Humans
- Kaplan-Meier Estimate
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation
- Polymerase Chain Reaction
- Quinazolines -- adverse effects
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.